Elucidation of the order of U1, U2, U4/U6, and U5 small nuclear ribonucleoprotein particle (snRNP) addition in spliceosome assembly and the roles of the snRNPs in the first and second trans-esterification reactions of pre-mRNA processing has been greatly augmented by genetic analysis of the yeast Saccharomyces cerevisiae (for recent reviews, see references 19 and 42) . However, studies of snRNP biogenesis have by and large been limited to biochemical assays of metazoan snRNPs. Little is known about the assembly of snRNPs in S. cerevisiae.
In metazoans, newly transcribed snRNAs are exported from the nucleus to the cytoplasm where they associate with core snRNP proteins (also known as Sm antigens) to form a presnRNP complex (see reference 2 and references therein). Assembly of these snRNP complexes is completed in the nucleus, in which the snRNPs then function in pre-mRNA splicing. The core snRNP proteins B, BЈ, D1, D2, D3, E, F, and G are instrumental in initiating snRNP assembly in the cytoplasm (28, 44 ). An ordered pathway for this process in which the D1, D2 and/or D3, E, F, and G proteins form an RNA-free 6S core cytoplasmic complex has been suggested (10, 45 ). This intermediate then assembles with the snRNA plus the B and BЈ proteins to form an 11S-15S particle that is subsequently transported into the nucleus. Association of core snRNP proteins with snRNA is necessary for cytoplasmic modifications of the snRNA, such as hypermethylation of the 5Ј cap of the snRNA (30) . Both of these events, the association of the snRNAs with the core proteins and the hypermethylation of the 5Ј cap, provide signals for reentry of the snRNA into the nucleus (11, 12) . Assembly of the snRNPs is completed by the addition of snRNP-specific proteins, which occurs either during or after the transport of the pre-snRNPs to the nucleus.
Do core snRNP proteins have specific functions during spliceosome assembly and pre-mRNA processing or do they serve merely to maintain snRNP structure and integrity? The study of mammalian and Xenopus core proteins has left this question largely unanswered. A second intriguing question arises from the existence of three similar yet distinct snRNP D proteins: D1, D2, and D3 (1, 27) . Do these three proteins represent a family of proteins with identical functions, or are there subtle differences in their roles in snRNP assembly and function? The genetic techniques available for S. cerevisiae make it an attractive system for addressing these questions.
The much lower abundance of snRNPs in S. cerevisiae compared with metazoans has made biochemical purification of core snRNP proteins from S. cerevisiae a difficult task. Furthermore, identification of core snRNP proteins has been largely refractile to the screens of temperature-sensitive mutants that have been employed for the isolation of the majority of defined yeast-splicing factors (reviewed in reference 18). However, several lines of evidence suggest that core snRNP proteins exist in S. cerevisiae. (i) Yeast U1, U2, U4, and U5 snRNAs contain the phylogenetically conserved Sm-binding site that has been demonstrated to directly associate with the core snRNP proteins in metazoans (17, 42) . At least in the case of the U5 snRNA, this Sm site is essential for cell viability (23) . ( ii) The Sm sites in the yeast snRNAs are functional upon injection into Xenopus oocytes. Injected yeast snRNAs are able to assemble with the Xenopus core snRNP proteins (36) . (iii) Antibodies directed against mammalian core snRNP proteins (Sm antisera) weakly coimmunoprecipitate the yeast U1, U2, U4, and U5 snRNAs (48, 50) . (iv) The identification of the yeast gene SMD1 encoding the functional homolog of the human D1 protein (40, 41) strengthens the possibility that other core snRNP proteins also exist in S. cerevisiae. (v) The recent isolation of the U1 and U4/U6.U5 snRNPs from S. cerevisiae (7) indicates that these snRNPs do indeed contain proteins that have sizes similar to those of the human core proteins.
We report here the characterization of a yeast gene SMD3 that encodes a second D core snRNP protein. The Smd3 protein is similar in sequence to the human D3 protein and is structurally related to the yeast and human D1 proteins. This work demonstrates that Smd3 is functionally distinct from Smd1. We show that Smd3 is required for yeast pre-mRNA splicing and that it associates with the U snRNAs. Our results also indicate that snRNP biogenesis in S. cerevisiae may parallel its mammalian counterpart.
MATERIALS AND METHODS
Strains, plasmids, and media. The strains used in this work are described in Table 1 . The techniques used for growing yeast and bacteria are described elsewhere (32, 47) . Yeast cells were transformed with DNA by the lithium acetate method (21) .
Diploid yeast strain BJ3434 is heterozygous for the pep3::LEU2 null allele of the nonessential PEP3 gene. The 5Ј 228 nucleotides (nt) of the adjacent SMD3 coding sequence were also deleted in this disruption (34) . A 0.95-kb EcoRI fragment containing SMD3 cloned in plasmid YCp50 (pYCp50-SMD3) was transformed into BJ3434. The resulting strain was subjected to sporulation, and tetrads were dissected. Strain JWY2445 was identified among the haploid progeny by screening for the desired phenotypes.
A null allele of SMD3 was created as follows. A 0.95-kb EcoRI fragment containing SMD3 was cloned into the EcoRI site of plasmid pRS314 (18) to generate pIB6. This plasmid contains a unique BglII site in the coding region of SMD3. A 1.7-kb BamHI fragment containing the entire HIS3 gene was purified from plasmid pHIS3CEN3 (15) and was inserted within SMD3 in the unique BglII site of pIB6, resulting in plasmid pIB14. A 2.6-kb EcoRI fragment from pIB14 containing smd3⌬2::HIS3 was purified and used to replace one copy of SMD3 in the diploid yeast strain JWY1401 by homologous recombination (39) .
The GAL1::SMD3 promoter fusion was constructed as follows. A 0.96-kb EcoRI-SalI fragment from the plasmid pBM258T (45a), containing the GAL1 promoter and transcription start sites, a multiple cloning site, and the CYC1 transcription terminator, was cloned into plasmid pRS314. The 0.95-kb EcoRI fragment from pIB6 was purified and further digested with the enzyme HinfI. A 460-bp fragment containing SMD3 was purified from the resulting fragments, made blunt ended with the Klenow enzyme, and cloned into the SmaI site of pRS314-GAL1. In this construct, nucleotide Ϫ35 with respect to the ATG of SMD3 is directly 3Ј of the GAL1 transcription start site, such that transcription of SMD3 is under the control of the GAL1 promoter. The plasmid containing the GAL1::SMD3 allele was transformed into yeast strain JWY2445. Strain JWY2450 was derived from the transformants upon loss of the YCp50-SMD3 plasmid on selective medium containing galactose and 5-fluoroorotic acid (5-FOA.)
The pGAL1::HD1 plasmid containing the human D1 gene fused to the GAL1 promoter was derived from the plasmid pHSMD1368 (38) (a gift from Sallie Hoch) as follows. A 1.2-kb EcoRI-SalI fragment from pHSMD1368, containing the GAL1::HD1 fusion, was cloned into the URA3-marked vector pUN75 (6) .
Yeast strains expressing epitope-tagged alleles of SMD3 were obtained by plasmid shuffling. Plasmids containing the epitope-tagged alleles of SMD3 (see below) were transformed into JWY2445. Subsequent loss of the YCp50-SMD3 plasmid was selected by using 5-FOA.
Growth curve and viability tests. Growth and viability of the JWY2450 yeast strain in galactose medium or after shifting to glucose medium were assayed as described previously (5) . Briefly, cells were grown in liquid medium containing galactose to mid-log phase (optical density at 610 nm, ϳ0.5) and were then diluted into medium containing either galactose or glucose. The optical densities of the cultures at 610 nm and cell viabilities were monitored. The cultures were diluted to keep all A 610 readings between 0.2 and 0.9 in order to maintain logarithmic growth.
Nucleic acid electrophoresis, transfer, and hybridization. The methods used for electrophoresis of DNA and RNA and nucleic acid transfer to Nytran membranes (Schleicher & Schuell, Keene, N.H.) were as described previously (32) . Radiolabeling of DNA probes and their hybridization to Nytran membranes were done as described previously (9) . A 370-bp DNA fragment internal to the CRY1 gene was generated by PCR and used as a probe to detect CRY1 premRNA and mature mRNA. A 2.2-kb EcoRI-HindIII DNA fragment containing the ACT1 gene was used as a probe for ACT1 pre-mRNA and mature mRNA. Yeast poly(A)
ϩ RNA was isolated as described by Couto et al. (4) . For detection of snRNAs, Northern blot analysis was done as follows. Total RNA or RNA extracted from immunoprecipitates (see below) was boiled for 5 min, and an equal volume of urea dye (8 M urea, 20% sucrose, 0.1% bromophenol blue, 0.1% xylene cyanol in 2ϫ Tris-borate-EDTA [pH 8.5]) was added. The sample was then subjected to electrophoresis on 5% acrylamide-7 M urea gels in 100 mM Tris-80 mM borate-1 mM EDTA (pH 8.5) (100 mM TBE) buffer for 5 h at 15 mA and electroblotted to Nytran membrane for 4 h in 50 mM TBE buffer at 35 V. The membranes were subsequently probed with 32 P-radiolabeled DNA complementary to snRNAs. These probes were generated by PCR of plasmids containing cloned snRNA genes. The intensity of the signal was quantified using the Ambis radioanalytic imaging system (Ambis, Inc., San Diego, Calif.). For detection of 5S rRNA, an oligonucleotide probe (5Ј-GGTAGATAT GGCCGCAACC-3Ј) was used. Hybridization of Nytran membranes to this oligonucleotide probe was done as described elsewhere (6) .
Epitope tagging of SMD3. Oligonucleotide sequences encoding the 9-aminoacid influenza virus hemagglutinin (HA) epitope (20) were inserted at the 5Ј and 3Ј ends of SMD3 by site-directed mutagenesis (25) . The 61-nt oligonucleotide JR1 (5Ј-CCAGAGAAACGATATGTCCAGCGTAGTCTGGGACGTCGTAT GGGTACTGTGCCTCATTTAA-3Ј) containing the sequences encoding the HA epitope and flanking sequences from SMD3 was used to insert the epitope sequences between codons 15 and 16 of SMD3 to construct the amino-terminustagged allele of SMD3 (SMD3HA-1). Similarly, the 60-nt oligonucleotide JR2 (5Ј-CGTTTCCTACCTAGCGTAGTCTGGGACGTCGTTGGGTATCTCT TAGGTCCTCT-3Ј) was used to insert the HA epitope between codons 100 and 101 in the wild-type SMD3 gene as well as in the SMD3HA-1 construct, resulting in the carboxy-terminus-tagged allele SMD3HA-2 and the doubly tagged SMD3HA-3 allele, respectively. For all of the constructs, the presence of the HA epitope was confirmed by restriction enzyme digestion and sequencing of the DNA. The tagged alleles were cloned into the yeast centromeric plasmid pRS314 (one to three copies per cell). The SMD3HA-1 and SMD3HA-3 alleles were also cloned into the yeast high-copy-number plasmid pRS424 (3) .
Epitope tagging of SMD1. A SMD1HA construct was made by PCR with the 5Ј oligonucleotide 5Ј-TTTTAGATCTATTATGAAGTTGGTTAACTTT-3Ј introducing a BglII site (underlined) and the 3Ј oligonucleotide 5Ј-ACCAGCAG CGAATCATAGAGCGTAGTCTGGAACGTCGTATGGGTA-3Ј introducing the nine codons of the HA epitope after the penultimate codon of SMD1. This PCR fragment was cloned into the SmaI site of vector pTZ19u (U.S. Biochemicals, Cleveland, Ohio); the presence of the HA epitope codons was confirmed by sequence analysis. A BglII-BamHI fragment containing the SMD1HA construct from this plasmid was inserted into the BamHI site of the pBM150 vector (22) . The correct orientation that places the SMD1HA gene under the control of the GAL1 promoter was identified by restriction digestion analysis. A diploid strain heterozygous for a null allele of SMD1 (SMD1/smd1::LEU2) has been previously described (40) . The URA3 marked plasmid containing GAL::SMD1HA was transformed into this strain, the transformants were sporulated, and asci were dissected on galactose-containing medium. Strain BZY1-16D was identified among the meiotic progeny by screening for the desired phenotype.
Preparation of splicing extracts and immunoinhibition of splicing. Splicing extracts were prepared from yeast strains JWY2455 and BJ2168 by the method described by Lin et al. (29) , with the modification that the spheroplasted cells were allowed to regenerate in rich medium containing 1.2 M sorbitol for 2 h at 30ЊC prior to homogenization. Extracts from yeast strains BZY1-7A, BZY1-16D, and JWY2456 were prepared as described elsewhere (29) , with the following modifications: strain BZY1-16D was grown in galactose-based medium; yeast cells were spheroplasted using lyticase (Sigma Chemical Co.) at a concentration of 400 U/ml by gently shaking for 1 h at 30ЊC; buffers A and D contained 0.5 mM phenylmethylsulfonyl fluoride; and extracts were not centrifuged after dialysis but were directly frozen in aliquots at Ϫ80ЊC. The activity of the extracts was checked by standard splicing reactions using an ACT1 pre-mRNA transcribed in vitro and radiolabeled with 32 P (29). For immunoinhibition experiments, 15 l of splicing extracts was incubated with 1 or 2 g of purified anti-HA antibody, diluted in buffer D (20% glycerol, 50 mM KCl, 0.2 mM EDTA, 0.5 mM dithiothreitol, 20 mM N-2-hydroxyethylpiperazine-NЈ-2-ethanesulfonic acid [HEPES], pH 7.9) for 1 h on ice, and subsequently assayed for splicing.
Immunoblot and immunoprecipitation analyses. Total proteins were extracted from yeast cells as described elsewhere (32) . For immunoblot analysis, protein samples were boiled in 1ϫ Laemmli buffer (26) and subjected to electrophoresis in sodium dodecyl sulfate (SDS)-10% polyacrylamide gels. Proteins were then transferred by electroblotting to a nitrocellulose membrane. The immunoblots were probed with anti-HA epitope monoclonal antibodies (a kind gift of Peter Kolodziej) and then incubated with goat anti-mouse immunoglobulin G antibodies conjugated to alkaline phosphatase (Promega Corp., Madison, Wis.) and developed according to the manufacturer's instructions. For Fig. 5B and 6A, proteins were subjected to electrophoresis in SDS-4 to 15% gradient polyacrylamide gels and transferred to polyvinylidene difluoride membranes.
For immunoprecipitation of the Smd1HA and Smd3HA-3 proteins, 1 g of purified anti-HA antibody 12CA5 (BAbCo, Berkeley, Calif.) was bound to 30 l of protein A-agarose beads (Bio-Rad Laboratories, Hercules, Calif.) in 0.1 M borate buffer, pH 8.2, at room temperature for 1 h and subsequently cross-linked as described elsewhere (46) . The protein A-antibody complexes were collected by brief centrifugation and washed extensively in buffer B (20 mM HEPES, pH 7.9, 50 mM NaCl, 0.05% Triton X-100). A 10-l volume of splicing extracts (20 mg of total protein per ml) from strain BZY1-16D, JWY2455, JWY2456, or BZY1-7A was diluted in buffer B (to a final volume of 80 l) and bound to the antibody beads for 1 h at room temperature. The immune complexes were collected by brief centrifugation and were washed six times with 1 ml of buffer B. Proteins were eluted in 1ϫ Laemmli sample buffer and subjected to immunoblot analysis as described above.
Coimmunoprecipitation of snRNAs was assayed as follows. The immune complexes were collected as described above, and the supernatant fractions were saved. The pellet was washed with buffer B as described above. After the last wash, all buffer B was removed and 300 l of proteinase K (PK) buffer (150 mM NaCl, 100 mM Tris-HCl, pH 7.5, 12.5 mM EDTA, 1% SDS) was added to the pellet fractions, the supernatant fractions, and 10 l of total splicing extract. The proteins were digested with proteinase K (U.S. Biochemicals) at a concentration of 0.4 mg/ml for 10 min at 37ЊC, which was followed sequentially by two extractions with phenol-chloroform-isoamyl alcohol and one extraction with chloroform. The RNA was ethanol precipitated in the presence of 100 l of 3 M sodium acetate, washed, suspended in 8 M urea dye, and subjected to Northern (RNA) analysis (see above). For experiments in which two consecutive immunoprecipitations were performed, the supernatants from the first precipitations were mixed with 30 l of fresh antibody-bound agarose and processed as described above.
Immunoprecipitations of 5 hypermethylated snRNAs. Cap modification of snRNAs was analyzed as follows. A 2-g amount of an anti-trimethylguanosine (TMG) antibody (a generous gift from James Friesen and Reinhard Lührmann) was bound to 50 l of immobilized protein A beads (Repligen Corporation, Cambridge, Mass.) in buffer B as described above. The protein A-antibody complexes were collected by brief centrifugation and washed in buffer B. A 10-g amount of total RNA were diluted with 50 l of buffer B, and the dilution was bound to the beads for 60 min at room temperature. For 15-or 20-h time points in glucose medium, approximately five times more RNA was coupled with 250 l of antibody beads solution. The immune complexes were collected and washed with buffer B. The immune complexes or supernatant fractions were incubated in buffer K (150 mM NaCl, 100 mM Tris-HCl, pH 7.5, 1% SDS, 2 mg of proteinase K per ml) for 1 h at 37ЊC. Digested proteins were removed by phenol extraction, and the RNA was precipitated with ethanol in the presence of 20 mg of glycogen per ml at Ϫ20ЊC. The RNA was then washed and suspended in water. Half of the RNA sample was used for RNA blot analysis.
Nuclear and cytoplasmic fractionations. Nuclear and cytoplasmic fractions of yeast cells were obtained by the method described elsewhere (52) . Proteins from equivalent amounts of nuclei or cytoplasm, i.e., nuclei and cytoplasm from equal numbers of cells, were subjected to immunoblot analysis as described above. Polyclonal antiserum to phosphoglucokinase was provided by Jeremy Thorner (University of California, Berkeley), and a monoclonal antibody to the 200-kDa subunit of RNA polymerase II was provided by Sha-Mei Liao and Richard Young (Massachusetts Institute of Technology, Cambridge). Quantification of bands on immunoblots was done using the optical image detection mode on the Ambis radioanalytic imaging system. Total RNA was extracted from equivalent amounts of nuclei or cytoplasm from approximately 2 ϫ 10 11 cells and suspended in 250 l of water. A 15-l volume of each sample was subjected to RNA blot analysis for detection of U snRNAs as above. These results were quantified as described above.
Indirect immunofluorescence microscopy. Yeast cells were prepared for indirect immunofluorescence microscopy as described elsewhere (35) . The primary antibody used was purified monoclonal anti-HA (see above) at a concentration of 50 g/ml. Rhodamine-conjugated anti-mouse immunoglobulin G (Cappel, Organon-Teknika Corp., Durham, N.C.) was used as the secondary antibody. Slides were viewed with a Zeiss Axiophot microscope equipped with a 100ϫ lens objective and Nomarski differential interference contrast (DIC) optics. Photographs were taken using a photometric cooled charge-coupled device (CCD) camera (Photometric Inc., Tucson, Ariz.) with 12-bit pixel depth. Subsequently, DIC images were flat-field divided to smooth out background and linearly stretched to 8-bit levels for display. Fluorescent images were likewise linearly contrast stretched.
DNA sequence analysis. DNA sequencing of HA-tagged SMD3 alleles, which were subcloned in pBluescript II KS(ϩ) plasmids (Stratagene, La Jolla, Calif.), was carried out by the dideoxy chain-termination method (43), using Sequenase version 2.0 (U.S. Biochemicals).
Analysis and comparisons of DNA sequences were performed by using computer programs developed by the Genetics Computer Group's Sequence Analysis software package at the University of Wisconsin Biotechnology Center, which was accessed through the Pittsburgh Supercomputing Center. VOL. 15, 1995 FUNCTIONALLY DISTINCT YEAST CORE snRNP Sm D PROTEINS 447 the sequences (BestFit program, Genetics Computer Group) based on the Dayhoff algorithm (also depicted by an alignment in Fig. 1A) indicates that the putative protein encoded by this ORF is 78% similar and 51% identical to the human D3 core snRNP protein. This degree of similarity is significant; the human D1 protein is functionally equivalent to the yeast Smd1 (41) , and its sequence is only 40% identical to that of Smd1 (40) . Thus, we have named this gene SMD3. The amino acid sequence of the predicted protein encoded by this ORF is also similar to that of the human core snRNP protein D1 (37) and its homolog in S. cerevisiae, Smd1 (40) (Fig. 1B) . The sequence of Smd3 is 50% similar and 26% identical to that of human D1 protein and 49% similar and 25% identical to that of yeast Smd1. Three metazoan D snRNP proteins, D1, D2, and D3, are core components of spliceosomal snRNPs (1, 27) . The mammalian D1, D2, and D3 proteins share considerable sequence similarity (29a). This structural similarity appears to be conserved in S. cerevisiae.
RESULTS
SMD3 is an essential, single-copy gene. A 32 P-radiolabeled 0.95-kb EcoRI DNA fragment containing the entire SMD3 ORF was hybridized to a Southern blot of yeast genomic DNA that was digested with EcoRI or BamHI. In each case, only one DNA fragment of the expected size was detected (Fig. 2B and data not shown), indicating that the SMD3 gene is present in one copy in the haploid yeast genome.
Previously, a null allele of PEP3 created by replacing sequences from PEP3 and the upstream ORF (SMD3) with LEU2 was found to be lethal (33a). However, the PEP3 gene was determined to be nonessential for vegetative growth (34) , from which it was inferred that the upstream ORF (SMD3) encodes an essential function. We confirmed this by two means. (i) We showed that a plasmid bearing only SMD3 was capable of rescuing the lethality of the pep3::LEU2 null allele. Therefore, in this paper, we refer to this allele as smd3⌬1:: LEU2. (ii) We constructed a null allele of SMD3, smd3⌬2:: HIS3, in which only sequences from the SMD3 coding region are deleted and replaced with HIS3. One copy of the wild-type SMD3 gene was replaced with this null allele in the diploid strain JWY1401 by homologous recombination. Genomic Southern blot analysis confirmed that the expected recombination events had occurred (data not shown). Upon sporulation of this heterozygous diploid, which was followed by tetrad dissection, only two viable spores were recovered from each of 20 tetrads. All of the meiotic offspring recovered were unable to grow on medium lacking histidine and therefore contained the wild-type allele of SMD3. This lethality can be complemented by a plasmid-borne 0.95-kb EcoRI fragment that contains all of the SMD3 coding region. Thus, SMD3 is essential for mitotic growth.
A blot of total yeast polyadenylated mRNAs fractionated by gel electrophoresis was probed with the 32 P-radiolabeled 0.95-kb EcoRI fragment containing all of the SMD3 ORF and 91 codons of the PEP3 ORF. Two mRNA species, approximately 3,100 and 440 nt long, were detected (Fig. 2C) . The larger mRNA is identical in size to the previously characterized PEP3 mRNA (34) . The size of the smaller mRNA is in agreement with the 303-nt ORF in the SMD3 sequence.
SMD3 is required for pre-mRNA splicing. To determine whether the SMD3 gene is necessary for pre-mRNA splicing, we constructed yeast strain JWY2450 (smd3⌬1::LEU2 plus pGAL1::SMD3), which is conditional for synthesis of Smd3, and assayed the effect of depletion of Smd3 on pre-mRNA splicing. The conditional null allele of SMD3 was constructed by placing the SMD3 coding region downstream of the yeast GAL1 promoter such that transcription of the GAL1::SMD3 allele is induced in galactose-containing medium and repressed in glucose-containing medium. SMD3 mRNA expressed from GAL1::SMD3 is present in the galactose-grown cultures at more than 10-fold higher levels than mRNA expressed from wild-type SMD3 in glucose or galactose medium (Fig. 3B and data not shown). RNA blot analysis shows that SMD3 mRNA expressed from the GAL1::SMD3 allele is not detectable 30 min after shifting strain JWY2450 to glucose-containing medium (Fig. 3B) . No change in the levels of a control RNA, snR189, was observed (data not shown).
The GAL1::SMD3 allele is fully functional since it can complement the lethality of the smd3⌬1::LEU2 null allele; strain JWY2450 grows in galactose medium with a doubling time of 4 h (Fig. 3A) . When shifted to glucose medium, this strain continues to grow logarithmically for about 15 h, after which the rate of growth decreases rapidly and ceases by about 30 h. We infer that this delayed decrease in growth rate results from overproduction of Smd3 in the galactose-grown cells, such that cessation of growth does not occur until subsequent dilution of Smd3 following several cell divisions in glucose medium.
To assess the effect of depletion of Smd3 on pre-mRNA splicing, we assayed the amounts of unspliced CRY1 premRNA and spliced CRY1 mRNA at various times after the shift in carbon source (Fig. 3B) . Spliced CRY1 mRNA, but not unspliced CRY1 pre-mRNA, was detected in cells grown in galactose medium or up to 4 h after shifting to glucose medium. At 15 h after the shift to glucose medium, concomitantly with the decrease in growth rate, CRY1 pre-mRNA accumulated; the ratio of unspliced CRY1 pre-mRNA to spliced CRY1 mRNA increased in glucose medium as the growth rate of the strain decreased. However, even at the latest time points, some CRY1 mRNA was detected. Identical results were obtained for a second intron-containing transcript, ACT1 (data not shown). In both cases, no splicing intermediates were observed upon shifting to glucose medium. Thus, Smd3 is necessary for efficient pre-mRNA splicing in vivo at a step or steps prior to the first cleavage and ligation reactions of splicing.
Depletion of Smd3 affects 5 cap modification and results in a decrease in the amounts of the spliceosomal U snRNAs. snRNP assembly in metazoans is dependent on association of the core snRNP proteins with the Sm-binding region of the U snRNAs (2). Disruption of this association can lead to decreased stability of the snRNAs (31, 51) . If the pathway for snRNP biogenesis in S. cerevisiae is similar to that in metazoans, then depletion of a yeast core snRNP protein might result in decreased levels of U snRNAs. To ascertain the effect of depletion of Smd3 on the accumulation of the yeast U snRNAs, we assayed levels of the U1, U2, U4, U5, and U6 snRNAs in the GAL1::SMD3 strain (JWY2450) at various times after shifting to glucose medium. We also determined the levels of 5S rRNA to serve as a control for loading. No effect on snRNA levels was observed 4 h after the medium shift, when premRNA splicing is apparently unaffected; the levels of snRNAs are identical to those in this strain grown in galactose medium ( Fig. 4A; compare lanes 1 and 2) . However, we observed a reduction in the levels of the U1, U2, U4, and U5 snRNAs 15 and 20 h after shifting to glucose-containing medium (Fig. 4A,  lanes 3 and 4) . There was little or no change in the levels of U6 snRNA and 5S rRNA at either time point. Quantification of the levels of the snRNAs, normalized with respect to 5S rRNA levels, showed that U5 snRNA levels decreased by 80%, U4 snRNA levels decreased by 60%, and U1 and U2 snRNA levels decreased by 50 and 40%, respectively. Thus, depletion of Smd3 results in a decreased accumulation of the U1, U2, U4, and U5 snRNAs. The levels of the different U snRNAs are reproducibly affected to different extents; levels of U5 snRNA are reduced to the greatest extent. The decreased accumulation could be due to a decrease in either the stability of the U snRNAs or else their synthesis. Currently, our experiments do not differentiate between these two possibilities. We determined whether depletion of Smd3 affects the 5Ј guanosine cap modification of the spliceosomal snRNAs. Total RNA extracted from the cells before and after Smd3 depletion was immunoprecipitated with antibodies that specifically recognize the modified TMG cap. The amounts of U snRNAs in the immunoprecipitate and supernatant fractions were assayed by RNA blot analysis (Fig. 4B) . In cells expressing Smd3 protein, approximately 50% of U1 snRNA, 40% of U2 snRNA, and 60% of the U4 and U5 snRNAs were immunoprecipitated by the anti-TMG antibody. We do not know whether the snRNAs remaining in the supernatant are not hypermethylated or whether this reflects the limited efficiency of the immunoprecipitation by the anti-TMG antibody. After depletion of Smd3, however, less than 5% of the U4 and U5 snRNAs and only 10% of U1 and U2 snRNAs were immunoprecipitated with the anti-TMG antibody. The ratio of snRNAs in the immunoprecipitate versus the supernatant decreases markedly after depletion of Smd3. Therefore, after Smd3 depletion, the majority of the remaining snRNAs are no longer immunoprecipitable with the anti-TMG antibody, suggesting that they do not contain hypermethylated 5Ј guanosine caps. Alternatively, depletion of Smd3 may result in decreased accessibility of the hypermethylated 5Ј guanosine caps to the anti-TMG antibody. However, we believe that the former possibility is more likely.
Immunological detection of Smd3 and Smd1. To further characterize the Smd3 protein, we tagged Smd3 with the in- The rate of growth of strain JWY2450 remains unchanged in galactose-containing medium but decreases in glucose-containing medium after seven generations and ceases completely by 30 h. The zero time point represents the point at which the cultures grown in galactose-containing medium were shifted to glucose-containing medium. Relative OD (optical density recorded at 610 nm) was measured as OD t /OD t ϭ 0 plotted on a logarithmic scale. (B) RNA was extracted from strain JWY2450 grown in galactose-medium and at different times after shifting to glucosecontaining medium (as indicated). RNA blot analysis shows that SMD3 mRNA is overexpressed in galactose medium and completely shut off in glucose medium. No SMD3 mRNA was detectable 30 min after shifting the cultures to glucose medium. The RNA blot was also probed with a 370-nt PCR fragment internal to the CRY1 gene showing that CRY1 pre-mRNA begins to accumulate in strain JWY2450 after 15 h in glucose medium and continues to accumulate up to 21 h in glucose medium. VOL. 15, 1995 FUNCTIONALLY DISTINCT YEAST CORE snRNP Sm D PROTEINS 449 fluenza virus HA epitope. Smd3 containing the nine-aminoacid HA epitope at either the amino or carboxy terminus could not be detected by immunoblot analysis of whole-cell extracts or splicing extracts of yeast strains expressing these tagged alleles. However, Smd3 containing the HA epitope at both positions (Smd3HA-3) was identifiable as an approximately 14-kDa polypeptide (Fig. 5A, lane 5) . This size is similar to those observed for the human D proteins (1, 27) . The identity of this polypeptide as Smd3HA-3 was confirmed by the fact that the amount of this polypeptide is greatly increased in extracts from a strain carrying SMD3HA-3 on a high-copynumber plasmid (Fig. 5A, lane 6 ). This protein is fully functional; yeast cells containing the smd3⌬1::LEU2 null allele and SMD3HA-3 on a low-copy-number CEN plasmid (strain JWY2455) grow at wild-type rates and splice CRY1 pre-mRNA as efficiently as wild-type cells (data not shown). The three human D proteins are similar in size to each other but can be distinguished from each other by SDS-polyacrylamide gel electrophoresis (26) . To determine whether epitopetagged Smd3HA-3 could be distinguished from Smd1, we constructed a GAL1::SMD1HA allele that expresses Smd1 tagged with the HA epitope at its carboxy terminus. Immunoblot analysis of cell extracts from strain BZY1-16D expressing Smd1HA and strain JWY2456 expressing Smd3HA-3 indicates that the two proteins are readily distinguishable from each other (Fig. 5B) . Smd1HA migrates in SDS-polyacrylamide gels as an 18.2-kDa polypeptide.
Antibodies against Smd3 inhibit splicing in vitro. We assayed whether anti-HA antibodies could inhibit splicing of extracts prepared from strain JWY2455 expressing only the epitope-tagged allele of SMD3 (SMD3HA-3). Extracts prepared from this strain are able to support splicing of an in vitro-transcribed ACT1 pre-mRNA in the presence of ATP (Fig. 5C, lanes 1 and 2) . Splicing was almost completely abolished if the extracts were preincubated with 1 or 2 l of anti-HA antibody (Fig. 5C, lanes 5 and 6) . Addition of identical volumes of buffer alone had no effect on the splicing reaction (Fig. 5C, lanes 3 and 4) . An identical experiment carried out with extracts from an untagged wild-type strain, BJ2168, showed that preincubation with the anti-HA antibodies did not affect splicing (Fig. 5C, lanes 7 to 12) .
Smd1 and Smd3 are associated with the spliceosomal U snRNAs. We tested whether Smd1 and Smd3 were core snRNP proteins associated with spliceosomal U snRNAs by assaying whether the snRNAs were coimmunoprecipitated with the anti-HA antibodies directed against epitope-tagged Smd1HA and Smd3HA-3. Splicing extracts prepared from strain BZY1-16D carrying the SMD1HA allele, strains JWY2455 and JWY2456 carrying the doubly tagged SMD3HA-3 alleles, and wild-type strain BZY1-7A were subjected to immunoprecipitation with the anti-HA antibody. Immunoblot analysis of the pellet and supernatant fractions (Fig. 6A) indicates that the Smd1HA and Smd3HA-3 proteins are immunoprecipitated from the respective epitope-tagged extracts. In a parallel experiment, RNA was extracted from the immune complexes and subjected to gel electrophoresis and RNA blot analysis. The U1, U2, U4, U5, and U6 snRNAs were specifically coimmunoprecipitated with the anti-HA antibody from extracts carrying the tagged alleles of SMD1 and SMD3 but not from untagged wild-type extracts (Fig. 6B) . Thus, both Smd1HA and Smd3HA-3 are associated with the U1, U2, U4, and U5 snRNAs, indicating that Smd1 and Smd3 are core components of these snRNPs. The coimmunoprecipitation of U6 snRNA may be indirect, since the majority of the U6 snRNAs in these extracts are associated with U4 snRNAs in U4/U6 snRNPs (8) . The U1 to U5 snRNAs were not completely immunoprecipitated by antibodies to either Smd3 or Smd1 (Fig. 6B ). This could be explained if a fraction of the SmD proteins associated with the snRNAs is not accessible to the antibody. Alternatively, the antibody-bead mixture may be saturated with the extracts. However, these possibilities seem unlikely, because almost all of the Smd1 protein as well as the Smd3 protein is immunoprecipitated with this antibody (Fig. 6A) . To determine whether the snRNAs remaining in the supernatant were capable of being further immunoprecipitated with the anti-HA antibody, we subjected the supernatants to a second identical immunoprecipitation. The majority of the U snRNAs remained in the supernatant of this second immunoprecipitation (Fig. 6B, lanes 7 to 12) . Therefore, it is likely that the snRNAs in the supernatant represent those that are not associated with Smd1 or Smd3.
SMD1 and SMD3 encode proteins with nonidentical functions. The SMD1 and SMD3 genes each encode essential proteins with significant sequence similarity that are both associated with the spliceosomal snRNAs. Smd1 and Smd3 may have identical functions; deletion of either gene may reduce the amount of SmD protein below a threshold required for viability. If such is true, then overexpression of one gene should compensate for the absence of the other. Alternatively, each gene product may perform unique essential functions, in which case overexpression of one will not compensate for the deletion of the other. To distinguish between these possibilities, we determined whether the lethality of a null allele of SMD1 could be overcome by overexpression of SMD3 and whether the lethality of a SMD3 null allele could be suppressed by overexpression of SMD1. Haploid yeast strain BRY100, which contains a smd1::LEU2 null allele at the SMD1 locus and pGAL1:: SMD1 (40), was transformed with plasmids containing SMD3 on low-and high-copy-number plasmid vectors. Transformants were tested for their abilities to lose the URA3-marked pGAL1::SMD1 plasmid by plating on selective medium containing 5-FOA. No 5-FOA-resistant colonies were obtained, indicating that the presence of low-or high-copy-number plasmids containing SMD3 does not suppress the smd1::LEU2 lethal phenotype.
To test whether overexpression of SMD1 could suppress the lethality of the smd3⌬1::LEU2 null allele, diploid strain BJ3434 (SMD3/smd3⌬1::LEU2) was transformed with pGAL1::SMD1. The resulting strain was sporulated, and tetrads were dissected on galactose-containing medium. No more than two viable spore clones per tetrad were obtained, all of which were Leu Ϫ . Thus, the pGAL1::SMD1 plasmid was unable to suppress the lethality of the smd3⌬1::LEU2 null allele. A null allele of SMD1 can be suppressed by expression of the human D1 gene under the transcriptional control of the yeast GAL1 promoter (41) . We determined whether overexpression of the human D1 protein could compensate for the loss of Smd3. Strain BJ3434 was transformed with pGAL1::HD1 and sporulated. Upon tetrad dissection, as described above, we failed to recover more than two viable spore clones per tetrad or any meiotic offspring that were leucine prototrophs. Thus neither overexpression of SMD1 nor the human D1 gene can suppress the lethality of the smd3⌬1::LEU2 null allele. We conclude that the proteins encoded by the SMD1 and SMD3 genes have qualitatively distinct functions in vivo.
There is a cytoplasmic pool of Smd3. snRNP assembly is a multistep process that begins in the cytoplasm. Cytoplasmic snRNA-free pools of several of the snRNP proteins are found in mammalian cells (44) as well as in Xenopus oocytes (13, 53) . To ascertain whether this is also the case in S. cerevisiae, the intracellular location of Smd3 was determined by indirect immunofluorescence microscopy utilizing a strain expressing the Smd3HA-3 epitope-tagged protein. We were unable to detect a signal above background from a strain that contained SMD3HA-3 on a centromeric plasmid. However, a strong signal was obtained in a strain expressing SMD3HA-3 from a high-copy-number plasmid (Fig. 7) . The Smd3HA-3 protein is localized both to the cytoplasm and the nucleus. The cytoplasmic staining is particulate in nature; however, we do not know whether this is biologically significant or is an artifact of the immunostaining procedure. The variation in the intensity of the signal between cells is probably a reflection of the differences in the copy numbers of the high-copy-number plasmid.
Overexpression of proteins can in some cases lead to their mislocalization. Therefore, we sought to confirm the above result by Western immunoblot analysis of nuclear and cytoplasmic fractions from a strain expressing SMD3HA-3 on a centromeric plasmid (Fig. 8) . Approximately half (55%) of the tagged Smd3 protein was found in the cytoplasmic fraction (Fig. 8A, lanes 3 and 4) . Identical results were obtained with a strain containing SMD3HA-3 on a high-copy-number plasmid (Fig. 8A, lanes 1 and 2) . Immunoblot assays with antibodies to the cytoplasmic proteins ribosomal protein L1 (5) and phosphoglucokinase (24) and the 200-kDa nuclear subunit of RNA polymerase II (49) were also carried out. For both yeast strains, the majority of the ribosomal protein L1 and phosphoglucokinase was found in the cytoplasmic fractions as expected (Fig. 8A) . RNA polymerase II was found predominantly in the nuclear fraction (85% was in the nuclear fraction and 15% was in the cytoplasmic fraction).
To determine the localization of the U snRNAs, we extracted RNA from equivalent amounts of nuclei and cytoplasm and performed RNA blot analysis for detection of the U1, U2, U4, U5, and U6 snRNAs (Fig. 8B) . Quantification of these results showed that 75% of U1 and U2 snRNAs were in the nuclear fraction and 80% of the U4 and U5 snRNAs were in the nuclear fraction and that the U6 snRNA was almost exclusively found (Ͼ90%) in the nuclear fraction. The small amount of the U snRNAs found in the cytoplasmic fractions may represent the steady-state levels of these snRNAs in the cytoplasm or may be due to experimental artifacts. We conclude that although there is possibly some leakage of nuclear components into the cytoplasm during our fractionation procedure, this cannot account for the amount of Smd3 that we find in the cytoplasmic fractions. Taken together with the immunofluorescence results, these data indicate that there is a cytoplasmic pool of yeast Smd3, as observed for metazoan core snRNP proteins. VOL. 15, 1995 FUNCTIONALLY DISTINCT YEAST CORE snRNP Sm D PROTEINS 451
DISCUSSION
We have characterized a gene, SMD3, encoding a core snRNP protein in S. cerevisiae. Like the previously identified yeast D1 core protein Smd1 (40) , the Smd3 protein is essential for pre-mRNA splicing and shares sequence similarity with the human D1 core snRNP protein. The three human D snRNP proteins D1, D2, and D3 are similar in sequence to each other; the sequence of Smd3 is most similar to that of the human D3 protein (29b). Therefore, it is highly likely that Smd3 is the homolog of the metazoan D3 core snRNP protein. A third yeast gene that encodes a protein similar in sequence to those of the human D proteins has been identified (3a) . These three yeast proteins possibly encode the yeast counterparts of metazoan core D snRNP proteins.
SMD3 is essential for vegetative growth, as is the case for the majority of yeast genes whose products are involved in premRNA processing (for a review, see reference 42). Depletion of Smd3 from yeast cells, using a GAL1::SMD3 conditional allele, results in accumulation of CRY1 and ACT1 pre-mRNAs. This suggests that Smd3 is required for splicing in vivo. However, splicing is not completely abolished even after shifting yeast cells bearing the GAL1::SMD3 allele to glucose medium for 21 h. At this time point, the growth rate of these cells is decreased considerably but some mature mRNA is still detectable. Similar results have been observed after depletion of U5 snRNA (33) or Smd1 (40) using GAL1 conditional alleles. It is likely that a decrease in growth rate occurs when expression (splicing) of one or more essential yeast genes becomes limiting. The residual splicing observed probably occurs in cells that still contain residual amounts of Smd3.
Antibodies against epitope-tagged Smd3 inhibit splicing in vitro, suggesting that Smd3 is required during spliceosome assembly or the trans-esterification reactions. However, previous studies with mammalian U4 snRNA have suggested that association of U4 snRNA with Sm proteins is dispensable for splicing in vitro (51) . Therefore, it is possible that Smd3 is FIG. 7 . Smd3 is localized in both the cytoplasm and nucleus of S. cerevisiae. Indirect immunofluorescence microscopy of strains JWY2449 (expressing untagged Smd3) (A) and JWY2456 (expressing Smd3HA-3 from a high-copy-number plasmid) (B) is shown. The panels depict yeast cells that are viewed by Nomarski optics; that are stained with 4Ј,6-diamidino-2-phenylindole (DAPI), which visualizes nuclear and mitochondrial DNA; and that are stained with anti-HA antibody. present in the active spliceosome but is not absolutely required for pre-mRNA splicing in vitro. The association of the antibody with the Smd3HA-3 antigen could interfere with spliceosome assembly or function by steric hindrance rather than by direct inactivation of Smd3 function. We assume that Smd3 is necessary for splicing in vivo because it is required for snRNP biogenesis. However, our data do not rule out the possibility that Smd3 also plays a direct role in the splicing process.
Smd3 migrates on SDS-polyacrylamide gels as a 14-kDa protein, very similarly to the human D3 protein (1, 27) . Unlike Smd1, the Smd3 protein does not appear to have a yeastspecific insertion in its sequence (41) . It does contain a highly charged carboxy-terminal tail which is also found in Smd1 and the human D1 protein (41) . It is possible that this highly charged region mediates binding to the snRNAs during snRNP assembly. The remainder of the protein could be involved in interactions with other core snRNP proteins or have functions in pre-mRNA splicing that have thus far not been tested for core snRNP proteins. Future studies of mutant alleles of SMD3 will help to investigate these possibilities.
Although the three core snRNP D proteins have similar sequences, Smd1 and Smd3 clearly do not have identical functions in S. cerevisiae. The lethal null allele smd3⌬1::LEU2 cannot be complemented by overexpression of SMD1, nor does the overexpression of SMD3 complement the smd1::LEU2 null mutation. The human D1, D2, and D3 proteins are associated with the U1, U2, U4/U6, and U5 snRNAs (27) . We observe coimmunoprecipitation of the U1, U2, U4/U6, and U5 snRNAs with antibodies against either Smd1 or Smd3. However, it is unclear whether all three D proteins, in either metazoans or S. cerevisiae, are components of the same snRNPs, i.e., whether each snRNP contains D1, D2, and D3, or whether there are separate populations of snRNPs containing only D1, D2, or D3. The former possibility seems more likely but has yet to be rigorously tested. In this regard, we note that the different U snRNAs are immunoprecipitated to different extents with antibodies against Smd1 and Smd3. For example, the U5 snRNA is reproducibly coimmunoprecipitated to a greater extent by antibodies to Smd3 than by antibodies to Smd1. This could merely be a reflection of the different extents to which the two epitopes are exposed to the antibody. More interestingly, however, this could indicate that different populations of snRNPs consisting of either Smd1 or Smd3 or neither coexist in S. cerevisiae. The isolation of genes encoding the yeast counterparts of the metazoan D core proteins not only provides a genetic tool for determining the differences in D protein functions but also can be used for the identification of yeast genes encoding other core snRNP proteins.
snRNP assembly in metazoans is mediated in the cytoplasm by association of the core snRNP proteins into an RNA-free 6S complex (2) . The D core proteins are among the first snRNP proteins to begin assembly, together with the E, F, and G polypeptides. This 6S complex of core snRNP proteins then associates with the B and BЈ proteins and newly transcribed U1, U2, U4, and U5 snRNAs that have been exported to the cytoplasm to form a pre-snRNP complex. However, the U6 snRNA is not exported to the cytoplasm but associates with the U4 snRNP in the nucleus during the final stages of snRNP assembly (2) . One might predict that the cytoplasmic snRNAs would be unstable in the absence of proper formation of the RNA-free core snRNP protein complex. This can be achieved in S. cerevisiae by depletion of one or more of the components of such a putative complex by the use of conditional alleles of core protein genes. Indeed, the depletion of Smd1 results in decreased levels of U1, U2, U4, and U5 snRNAs but does not affect the levels of U6 snRNA (40) . We observe identical results upon depletion of Smd3, suggesting that snRNP assembly in S. cerevisiae may occur by a pathway that is very similar to that in metazoans. Upon depletion of Smd1 or Smd3, we reproducibly observe that the levels of the different U snRNAs are reduced to different extents. Furthermore, the patterns are not identical for Smd1 and Smd3. It is not clear whether these differences reflect different rates of assembly of snRNPs or other mechanisms.
Our results also show that the amount of snRNAs immunoprecipitable by anti-TMG antibodies is greatly reduced upon depletion of Smd3. In metazoans, hypermethylation of the 7-methyl cap occurs in the cytoplasm after assembly of the snRNAs with the core snRNP proteins (30) . The modified cap provides one of the signals that targets the pre-snRNP complex to the nucleus (11, 16) . Upon depletion of Smd3 in S. cerevisiae, a pre-snRNP complex might not form, resulting in incomplete, inappropriate, or no snRNA cap modification. We suggest that lack of cap modification and/or lack of binding to a core snRNP protein targets the snRNAs for degradation. An alternative explanation is that Smd3 functions in the stabilization of snRNPs after they have formed. However, given the similarity of Smd3 to human D proteins and the demonstration that the D proteins are directly involved in snRNP biogenesis in higher eukaryotes (10) , it is more likely that Smd3 has a similar role in S. cerevisiae.
Studies of mouse fibroblast cells and fully mature Xenopus oocytes have shown that unlike other splicing factors, the core snRNP proteins, especially the B, BЈ, and D proteins, are stored in the cytoplasm as large RNA-free pools (13, 14, 44) . Synthesis of snRNAs and assembly of snRNPs in mouse fibroblasts occur normally for over 1 h after inhibition of protein synthesis (13, 14, 44) . Pulse-chase experiments with these cells have determined that the half-life of radiolabeled B, BЈ, and D proteins in the cytoplasm is about 2 h. Upon chasing with unlabeled proteins, these radiolabeled proteins move rapidly to the nucleus, presumably as a part of the pre-snRNP complex.
We determined the intracellular location of Smd3 by both 2) , containing SMD3HA-3 on a high-copy-number plasmid, and strain JWY2455 (lanes 3 and 4) , containing SMD3HA-3 on a low-copy-number (centromeric) plasmid, were partitioned into cytoplasmic and nuclear fractions. (A) Equivalent amounts of each fraction were subjected to immunoblot analysis and probed with anti-HA antibodies, polyclonal antisera against ribosomal protein L1 (rpL1) or phosphoglucokinase, and a monoclonal antibody against RNA polymerase II. (B) RNA from equivalent amounts of nuclei and cytoplasm was extracted and subjected to RNA blot analysis for detection of U1, U2, U4, U5, and U6 snRNAs. N, nuclear fraction; C, cytoplasmic fraction.
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on March 1, 2013 by PENN STATE UNIV http://mcb.asm.org/ indirect immunofluorescence microscopy and Western immunoblot analysis of nuclear and cytoplasmic fractions. We observed a strong fluorescent staining in the cytoplasm and a weaker nuclear staining. Cell fractionation determined that about half of the Smd3 protein is localized in the cytoplasmic fractions; a substantially smaller fraction of U snRNAs was present in the cytoplasmic fractions. This evidence strongly suggests that a large pool of Smd3 exists in the cytoplasm. The majority of this pool of Smd3 may not be associated with snRNAs but rather may represent free Smd3 protein or complexes of RNA-free core proteins. This hypothesis is consistent with the immunoprecipitation results in Fig. 6 , in which most of the SmD proteins are immunoprecipitated with the anti-HA antibody but only a portion of the snRNAs are coimmunoprecipitated. With the availability of antibodies against the other yeast D core proteins, future experiments can test whether the cytoplasmic pool of Smd3 is associated with them. Such studies will provide further insights into the mechanism of yeast snRNP biogenesis.
